Spacetek Technology AG has successfully completed its seed financing round in October 2023. Led by Swisscom Ventures, 5.8 million CHF in funding has been secured from a group of financial investor .
The Company’s expertise focuses on profiling the patient’s immune response to their cancer with blood-based proteomic solutions, in addition to genomic insights.